A GLP-1 program built around your biology, not a standard starter dose handed to everyone who walks in.
At Denver Wellness & Aesthetics Center (DWAC), GLP-1 therapy is led by Dr. Michael Young, a double board-certified physician in Family and Lifestyle Medicine, and built into a broader longevity and metabolic health strategy rather than offered as a standalone injection program.
GLP-1 receptor agonists, including semaglutide and tirzepatide, mimic a hormone your body already produces called glucagon-like peptide-1. This hormone slows stomach emptying, increases the feeling of fullness, and helps regulate blood sugar. The practical result for most patients is reduced appetite, fewer cravings, and steady, sustained fat loss when the medication is paired with the right nutritional and lifestyle support.
Two patients on the same GLP-1 medication can have very different experiences depending on dose titration, nutritional support, and monitoring.
At DWAC, GLP-1 therapy starts with a thorough assessment, including relevant biomarkers and health history, so your starting dose and titration schedule reflect your actual physiology rather than a generic protocol.
GLP-1 therapy is generally considered for adults working to lose weight who have not achieved their goals through diet and exercise alone, or who have weight-related health conditions that would benefit from medical support.
Certain health conditions and medications can affect candidacy, which is why every program at DWAC starts with a real evaluation rather than a questionnaire and a prescription.
A thorough review of your health history, goals, and relevant biomarkers with Dr. Young or a member of the clinical team.
Your starting medication, dose, and titration schedule are set based on your specific profile, not a fixed protocol.
Regular check-ins to monitor progress, adjust your plan, and manage any side effects, alongside nutrition and lifestyle guidance.
GLP-1 therapy at DWAC is positioned within your broader health picture, including hormone balance and metabolic health, rather than treated as an isolated weight loss tool.
Both are GLP-1 medications that reduce appetite and support weight loss. Tirzepatide also acts on a second receptor, GIP, which for some patients supports additional metabolic benefit. Your provider will help determine which fits your situation.
Your starting dose and titration schedule are based on your health history, goals, and how your body responds over time, not a fixed protocol applied to every patient.
The most commonly reported effects include nausea, digestive changes, and appetite suppression, especially during dose increases. Your care team monitors your progress and can adjust your plan to help manage these effects.
DWAC’s program is physician-led and includes a real evaluation, biomarker review where appropriate, and ongoing monitoring, rather than a questionnaire and an automatic prescription.
Yes. Many patients pair GLP-1 therapy with hormone optimization, peptide therapy, or GLP-1 microdosing for longevity support, depending on their goals. Learn about GLP-1 microdosing.
Retatrutide is a newer, more advanced option in this medication class. Learn more about retatrutide or ask about it at your consultation.
Nutritional guidance is part of your program, since GLP-1 medications work best alongside adequate protein intake and balanced eating, not in place of it.
Timelines vary by individual goals and response. Your provider will discuss an expected timeline and long-term maintenance strategy as part of your personalized plan.
Every GLP-1 program begins with a physician evaluation. Call (303) 347-2000 or request a consultation below.
(303) 347-2000 · 500 E Hampden Ave, Suite 206 · Englewood, CO 80113
